| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |